| 0 (0%) | 05-30 08:30 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 82.9 |
1-year : | 96.83 |
| Resists | First : | 70.98 |
Second : | 82.9 |
| Pivot price | 57.52 |
|||
| Supports | First : | 56.77 |
Second : | 48 |
| MAs | MA(5) : | 65.1 |
MA(20) : | 57.7 |
| MA(100) : | 49.95 |
MA(250) : | 38.71 |
|
| MACD | MACD : | 2.6 |
Signal : | 1.2 |
| %K %D | K(14,3) : | 88.8 |
D(3) : | 90.9 |
| RSI | RSI(14): 64.8 |
|||
| 52-week | High : | 70.98 | Low : | 23.29 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ TWST ] has closed below upper band by 12.2%. Bollinger Bands are 114.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 71.08 - 71.44 | 71.44 - 71.74 |
| Low: | 65.85 - 66.21 | 66.21 - 66.51 |
| Close: | 66.34 - 66.91 | 66.91 - 67.37 |
Fri, 29 May 2026
TWST (NASDAQ) affiliate reports sales of 425, 354, 1,962, 1,642 shares - Stock Titan
Fri, 29 May 2026
TWST (TWST) reports insider sales of 11,616 shares and scheduled vesting - Stock Titan
Thu, 28 May 2026
Emily Leproust sells TWST shares in multiple 2026 transactions (TWST) - Stock Titan
Thu, 28 May 2026
Twist Bioscience(TWST.US) Officer Sells US$3.21 Million in Common Stock - Moomoo
Thu, 28 May 2026
Twist Bioscience (TWST) director sells 500 shares at $61.04 under 10b5-1 plan - Stock Titan
Thu, 28 May 2026
Twist Bioscience (TWST) CEO Leproust sells 49,299 shares via 10b5-1 plan - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 62 (M) |
| Shares Float | 55 (M) |
| Held by Insiders | 1.3 (%) |
| Held by Institutions | 123.4 (%) |
| Shares Short | 13,910 (K) |
| Shares Short P.Month | 14,150 (K) |
| EPS | -1.33 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.32 |
| Profit Margin | -19.9 % |
| Operating Margin | -35 % |
| Return on Assets (ttm) | -13 % |
| Return on Equity (ttm) | -18.2 % |
| Qtrly Rev. Growth | 19.2 % |
| Gross Profit (p.s.) | 3.42 |
| Sales Per Share | 6.57 |
| EBITDA (p.s.) | -1.77 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -56 (M) |
| Levered Free Cash Flow | -58 (M) |
| PE Ratio | -50.66 |
| PEG Ratio | 0 |
| Price to Book value | 9.13 |
| Price to Sales | 10.16 |
| Price to Cash Flow | -74.91 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|